Florian Lucasson a, Andra Balanescu b, Uta Kiltz c, Ying-Ying Leung d, Sibel Zehra Aydin e, Inna Gaydukova f, Ennio Lubrano g, Laura C. Coates h, Maarten de Wit i, Ana-Maria Orbai j, Laure Gossec a, k, ⁎
a Inserm, Institut Pierre-Louis d’Épidémiologie et de Santé Publique, Sorbonne Université, 75013 Paris, France
b Department of Internal Medicine and Rheumatology, “Carol Davila” University of Medicine and Pharmacy, “Sf. Maria” Hospital, Bucharest, Romania
c Rheumazentrum Ruhrgebiet, Herne and Ruhr-Universität, Bochum, Germany
d Duke-NUS Medical School, Singapore General Hospital, Singapore, Singapore
e The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
f North-western State medical university, Saint-Petersburg, Russia
g Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, University of Molise, Campobasso, Italy
h Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
i Patient research partner, Amsterdam, Netherlands
j Division of Rheumatology, Psoriatic Arthritis Program, Johns-Hopkins University School of Medicine, Baltimore, MD, USA
k Rheumatology department, Pitié Salpétrière hospital, AP–HP, Paris, France